Yesterday, the Food and Drug Administration (FDA) issued a warning that silicone and saline breast implants may be associated with a rare form of cancer. The cancer, known as anaplastic large cell lymphoma (ALCL), has been found in 34 women with breast implants. ALCL has been found in the capsule surrounding the implant, but not the breast tissue itself. The FDA concluded that there may be a link between breast implants and ALCL after examining scientific literature that described ALCL in 34 women with breast implants, as well as data from national and international regulatory agencies, scientific experts, and breast implant manufacturers. In most cases. ALCL was found years after breast implant surgery.
It is estimated that 5-10 million women worldwide have breast implants. With only 34 cases of ALCL described, it’s impossible to say at this time that breast implants cause ALCL. Even though the risks of getting ALCL with breast implants, if real, are exceedingly small, given that the usual incidence is around 1 in 500,000, it’s important to investigate this matter more thoroughly. To that end, the FDA and the American Society of Plastic Surgeons (ASPS) are establishing a registry of ALCL patients who have breast implants. FDA scientists hope the registry yields enough information to better understand what the risks for developing ALCL are for women with breast implants.
Ultimately, what’s a patient to do? If the risk of getting ALCL from breast implants is real, it is exceedingly small. Says Caroline Hove, spokesperson for Allergan in an article from the Wall Street Journal, “”A woman is more likely to be struck by lightning than get this condition.” That being said, ALCL has the potential to be fatal; the informed patient should be aware of this very small but possibly significant risk associated with breast implants.
Many patients like to pose the question, “Am I ready for a facelift?” The truth is that there is no good answer to this question. Face lift is an elective procedure. It is particularly good at treating hollowing of the cheeks, prominent nasolabial folds (parenthesis deformity), jowls, and general heavy facial sagging. The invasiveness of the procedure usually correlates to the amount of deformity that a patient has. Specifically, patients in their early 40s are oftentimes good candidates for minimally invasive face lifts, which would involve a short scar and less manipulation of the deep tissues of the face. More advanced facial aging oftentimes requires a full face lift, with extensive treatment of the neck and more extensive reshaping of the deeper soft tissues. The amount of swelling with both procedures can range anywhere from 10-21 days, and has much to do with a patient’s intrinsic physiology.
The bottom line is, if you are motivated to undergo a more permanent correction of your facial aging, it may be an appropriate time to consider facial cosmetic surgery. If you are not motivated, noninvasive treatment with products such as Botox, Dysport and facial fillers, including Juvéderm, Restylane, and Radiesse, may be a better option.
Ultimately, if you have questions about treatment to reverse the signs of facial aging, your best bet is to seek consultation with a board certified plastic surgeon. If you would like to contact Dr. Jejurikar, please call his office at 214-827-2814.
With the economic recession in the United States, more people are working longer and are seeking an advantage for maintaining a youthful appearance in the work place. Although this may not improve one’s job performance, many times, particularly when looking for new employment, a competitive advantage can be obtained by looking more refreshed and more youthful. In the last year, it has become apparent that Botox and its competitor, Dysport, are being performed with more and more frequency for precisely this purpose. These treatments help eliminate dynamic wrinkles, particularly crow’s feet around the eyes, frown lines between the eyebrows, and lines across the forehead. With relatively simple and quick office injection of Botox or Dysport, wrinkles can disappear within just a matter of days.
The cost of Botox and Dysport varies, depending on the amount of product used and the areas treated. In general, patients can expect to pay between $350-$700 per treatment. Results generally last from 3 to 6 months.
Should you have questions about this procedure or other noninvasive procedures to gain a competitive advantage in the workplace, do not hesitate to contact Dr. Jejurikar’s office at 214-827-2814. Dr. Jejurikar is a board certified plastic surgeon with convenient office locations in Dallas and Plano.
Many patients come to the office, complaining about the appearance of their nasal hump. Some of the patients want the hump to go away, but don’t necessarily want surgery to fix it.
The great news is that dermal fillers can be used to correct this. The most commonly used filler used for this is Radiesse, which is made out of calcium hydroxylapatite. Although the results are not permanent, they generally last 12-18 months. Radiesse is not a great treatment for and overly long or short nose, a wide or bulbous nasal tip, or an overly wide nose.
If you are troubled by the appearance of your nose, and you would like to learn more about nonsurgical nose jobs and surgical rhinoplasty, do not hesitate to contact Dr. Jejurikar’s office at 214-827-2814.